Cargando…
Utility of Immunohistochemistry and Western Blot in Profiling Clinically Suspected Cases of Congenital Muscular Dystrophy
OBJECTIVE: Immunocharacterization of congenital muscular dystrophy (CMD) to determine the frequency of various subtypes in a large Indian Cohort. MATERIALS AND METHODS: This retrospective (2014-2017) study was carried on muscle biopsies of clinically suspected cases of CMD with histological evidence...
Autores principales: | , , , , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Wolters Kluwer - Medknow
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8232506/ https://www.ncbi.nlm.nih.gov/pubmed/34220063 http://dx.doi.org/10.4103/aian.AIAN_18_20 |
_version_ | 1783713651633422336 |
---|---|
author | Mhatre, Radhika Sekar, Deepha Ponmalar, Jessiena Nagappa, Madhu Veeramani, Preethish-Kumar Polavarapu, Kiran Vengalil, Seena Atchayaram, Nalini Narayanappa, Gayathri |
author_facet | Mhatre, Radhika Sekar, Deepha Ponmalar, Jessiena Nagappa, Madhu Veeramani, Preethish-Kumar Polavarapu, Kiran Vengalil, Seena Atchayaram, Nalini Narayanappa, Gayathri |
author_sort | Mhatre, Radhika |
collection | PubMed |
description | OBJECTIVE: Immunocharacterization of congenital muscular dystrophy (CMD) to determine the frequency of various subtypes in a large Indian Cohort. MATERIALS AND METHODS: This retrospective (2014-2017) study was carried on muscle biopsies of clinically suspected cases of CMD with histological evidence of dystrophy/myopathic features. Immunohistochemistry (IHC) to antibodies against laminin (α2, α5,β1,γ1), Collagen-VI (A1,2,3), and Western blot (WB) for α-dystroglycan and POMT1 was performed. RESULTS: The study included 57 cases, of which 15 cases (26.3%) had mean age at presentation of 3.5 years, M: F = 1.5:1, elevated creatinine kinase (CK) (mean 1657 U/L), global developmental delay, multiple contractures, abnormal facies, white matter hyperintensities and showed laminin-α2 deficiency (Merosin deficient CMD). In addition, secondary reduction in laminin-β1, over-expression of laminin-α5, and preserved laminin-γ1 was noted. Ullrich CMD constituted 11/57 cases (19.2%) with mean age at presentation of 5.3 years, M: F = 1.2:1 and normal CK. They presented with proximal muscle weakness, soft velvety palms and soles, contractures, and joint hyperextensibility. Collagen-VI (A1,2,3) showed either complete (n = 3) or sarcolemmal specific (n = 8) loss of staining. Out of the remaining 31 cases, WB for α-dystroglycan was performed in 17 cases which showed deficiency in seven (12.3%). Three of these in addition revealed secondary partial loss of laminin-α2. WB for POMT1 showed deficiency in a single case clinically diagnosed Walker–Warburg syndrome, who presented with seizures and classical features of pachygyria, lissencephaly, and cerebellar cyst on MRI. Twenty-four cases (42.2%) remained uncharacterized and need genetic evaluation. CONCLUSION: The study helped in characterizing 57.8% of the proband. Immunotyping helps to direct mutational analysis for targeted genes and offers a potential route for prenatal diagnosis. |
format | Online Article Text |
id | pubmed-8232506 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2021 |
publisher | Wolters Kluwer - Medknow |
record_format | MEDLINE/PubMed |
spelling | pubmed-82325062021-07-02 Utility of Immunohistochemistry and Western Blot in Profiling Clinically Suspected Cases of Congenital Muscular Dystrophy Mhatre, Radhika Sekar, Deepha Ponmalar, Jessiena Nagappa, Madhu Veeramani, Preethish-Kumar Polavarapu, Kiran Vengalil, Seena Atchayaram, Nalini Narayanappa, Gayathri Ann Indian Acad Neurol Original Article OBJECTIVE: Immunocharacterization of congenital muscular dystrophy (CMD) to determine the frequency of various subtypes in a large Indian Cohort. MATERIALS AND METHODS: This retrospective (2014-2017) study was carried on muscle biopsies of clinically suspected cases of CMD with histological evidence of dystrophy/myopathic features. Immunohistochemistry (IHC) to antibodies against laminin (α2, α5,β1,γ1), Collagen-VI (A1,2,3), and Western blot (WB) for α-dystroglycan and POMT1 was performed. RESULTS: The study included 57 cases, of which 15 cases (26.3%) had mean age at presentation of 3.5 years, M: F = 1.5:1, elevated creatinine kinase (CK) (mean 1657 U/L), global developmental delay, multiple contractures, abnormal facies, white matter hyperintensities and showed laminin-α2 deficiency (Merosin deficient CMD). In addition, secondary reduction in laminin-β1, over-expression of laminin-α5, and preserved laminin-γ1 was noted. Ullrich CMD constituted 11/57 cases (19.2%) with mean age at presentation of 5.3 years, M: F = 1.2:1 and normal CK. They presented with proximal muscle weakness, soft velvety palms and soles, contractures, and joint hyperextensibility. Collagen-VI (A1,2,3) showed either complete (n = 3) or sarcolemmal specific (n = 8) loss of staining. Out of the remaining 31 cases, WB for α-dystroglycan was performed in 17 cases which showed deficiency in seven (12.3%). Three of these in addition revealed secondary partial loss of laminin-α2. WB for POMT1 showed deficiency in a single case clinically diagnosed Walker–Warburg syndrome, who presented with seizures and classical features of pachygyria, lissencephaly, and cerebellar cyst on MRI. Twenty-four cases (42.2%) remained uncharacterized and need genetic evaluation. CONCLUSION: The study helped in characterizing 57.8% of the proband. Immunotyping helps to direct mutational analysis for targeted genes and offers a potential route for prenatal diagnosis. Wolters Kluwer - Medknow 2021 2020-07-24 /pmc/articles/PMC8232506/ /pubmed/34220063 http://dx.doi.org/10.4103/aian.AIAN_18_20 Text en Copyright: © 2006 - 2021 Annals of Indian Academy of Neurology https://creativecommons.org/licenses/by-nc-sa/4.0/This is an open access journal, and articles are distributed under the terms of the Creative Commons Attribution-NonCommercial-ShareAlike 4.0 License, which allows others to remix, tweak, and build upon the work non-commercially, as long as appropriate credit is given and the new creations are licensed under the identical terms. |
spellingShingle | Original Article Mhatre, Radhika Sekar, Deepha Ponmalar, Jessiena Nagappa, Madhu Veeramani, Preethish-Kumar Polavarapu, Kiran Vengalil, Seena Atchayaram, Nalini Narayanappa, Gayathri Utility of Immunohistochemistry and Western Blot in Profiling Clinically Suspected Cases of Congenital Muscular Dystrophy |
title | Utility of Immunohistochemistry and Western Blot in Profiling Clinically Suspected Cases of Congenital Muscular Dystrophy |
title_full | Utility of Immunohistochemistry and Western Blot in Profiling Clinically Suspected Cases of Congenital Muscular Dystrophy |
title_fullStr | Utility of Immunohistochemistry and Western Blot in Profiling Clinically Suspected Cases of Congenital Muscular Dystrophy |
title_full_unstemmed | Utility of Immunohistochemistry and Western Blot in Profiling Clinically Suspected Cases of Congenital Muscular Dystrophy |
title_short | Utility of Immunohistochemistry and Western Blot in Profiling Clinically Suspected Cases of Congenital Muscular Dystrophy |
title_sort | utility of immunohistochemistry and western blot in profiling clinically suspected cases of congenital muscular dystrophy |
topic | Original Article |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8232506/ https://www.ncbi.nlm.nih.gov/pubmed/34220063 http://dx.doi.org/10.4103/aian.AIAN_18_20 |
work_keys_str_mv | AT mhatreradhika utilityofimmunohistochemistryandwesternblotinprofilingclinicallysuspectedcasesofcongenitalmusculardystrophy AT sekardeepha utilityofimmunohistochemistryandwesternblotinprofilingclinicallysuspectedcasesofcongenitalmusculardystrophy AT ponmalarjessiena utilityofimmunohistochemistryandwesternblotinprofilingclinicallysuspectedcasesofcongenitalmusculardystrophy AT nagappamadhu utilityofimmunohistochemistryandwesternblotinprofilingclinicallysuspectedcasesofcongenitalmusculardystrophy AT veeramanipreethishkumar utilityofimmunohistochemistryandwesternblotinprofilingclinicallysuspectedcasesofcongenitalmusculardystrophy AT polavarapukiran utilityofimmunohistochemistryandwesternblotinprofilingclinicallysuspectedcasesofcongenitalmusculardystrophy AT vengalilseena utilityofimmunohistochemistryandwesternblotinprofilingclinicallysuspectedcasesofcongenitalmusculardystrophy AT atchayaramnalini utilityofimmunohistochemistryandwesternblotinprofilingclinicallysuspectedcasesofcongenitalmusculardystrophy AT narayanappagayathri utilityofimmunohistochemistryandwesternblotinprofilingclinicallysuspectedcasesofcongenitalmusculardystrophy |